Bicycle Therapeutics Plc American Depositary Shares | BCYC

AI Analysis of Bicycle Therapeutics Plc American Depositary Shares

Bicycle Therapeutics dropped to day and moved down -3.41% It looks like BCYC may be interacting with a slightly angled resistance line. This area could represent a pivot point. We can also take into account momentum, Bicycle Therapeutics has been a pretty poor performer over the last year and hasn't done much better over the last three months either. Over the past year, investors in the asset have lost -44.89 percent of their money, well any that are still holding have. More will probably sell into any strength to mitigate risk.

If the price breaks through the resistance level it will probably move up to the $5.15 where it may meet further resistance. We aren't seeing very clear support levels down beneath this point, so it might have room to gap down lower if price is rejected from here.

Analyst Ratings for Bicycle Therapeutics By Price Target And Rating

The analysts are pretty neutral on Bicycle Therapeutics right now, so not much useful information here. The current Analysts Sentiment Score is 1.67. Most companies range between (-200 to 200).

Here's a break down of the latest rating changes. Canaccord Genuity Group reiterated a rating of Buy on 2024-02-21 and provided a price target of $60.00. Needham & Company LLC announced that they are reiterating a rating of Buy on 2024-02-21 and they set their price target at $43.00. HC Wainwright announced a lowering of their price target to $55.00 from $57.00 on 2024-02-21. JMP Securities announced a lowering of their price target to $32.00 from $44.00 on 2023-12-20. Cantor Fitzgerald announced that they are reiterating a rating of Overweight on 2023-11-08 and they set their price target at $65.00. Morgan Stanley announced a lowering of their price target to $40.00 from $42.00 on 2023-11-03. On 2023-09-11 B. Riley upgraded Bicycle Therapeutics from Neutral to Buy and added a price target of $33.00. EF Hutton Acquisition Co. announced that they are reiterating a rating of Buy on 2023-04-19 and they set their price target at $55.00.

Earnings Per Share (EPS) Estimates By Year and Quarter

Short interest for Bicycle Therapeutics

We take into account several different measures of short interest to create a composite score. These measures are shown in the chart below. Short selling is when investors are betting against a stock. We compile these factors to create a dynamic Short Score - this can indicate poor sentiment, internal problems with a company or industry and the anticipation of future price declines. We look at the short interest percent, days to cover, the rate of change and total shares sold short.

Social Sentiment for Bicycle Therapeutics

Social Sentiment is an aggregation of several different factors such as news, articles, blogs, user content, ratings, etc. Which is shown in the chart below. It may become predictive of a reversal if price and the sentiment diverge. Broader market forces may push prices up or down but if market participants maintain a different view on a specific stock, it may be taken as an opportunity to buy or sell in those cases.